Valuation : Berkley Renewables Inc.

Market Cap 364K 315K 295K 269K 507K 34.75M 509K 3.5M 1.37M 17.58M 1.37M 1.34M 58.34M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.43M 4.15M 3.79M 7.13M 489M 7.16M 49.16M 19.2M 247M 19.24M 18.82M 821M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 2002-06-19
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 2006-08-16
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
+0.64%-3.35%+31.71%+10.79% 157B
-1.29%-3.77%+56.68%+56.99% 101B
-0.80%-6.34%+14.85%+12.12% 75.19B
-0.12%-3.59%+24.13%-5.29% 59.08B
-0.07%-3.26%+92.25%+66.45% 58.29B
-1.42%-6.19%+32.88%+30.74% 55.35B
+0.49%-3.56%+31.16%-6.66% 54.45B
+0.84%-4.47%+22.19%-15.39% 44.02B
+0.57%-0.19%+39.95%+10.67% 33.97B
Average -0.12%-3.64%+38.42%+17.82% 63.8B
Weighted average by Cap. -0.15%-4.06%+38.34%+20.29%

Financials

2016 2017
Net sales 1.03M 893K 837K 764K 1.44M 98.61M 1.44M 9.92M 3.87M 49.88M 3.88M 3.8M 166M 1.72M 1.49M 1.4M 1.27M 2.4M 164M 2.41M 16.54M 6.46M 83.21M 6.48M 6.33M 276M
Net income 173K 149K 140K 128K 240K 16.47M 241K 1.66M 647K 8.33M 648K 634K 27.65M -631K -544K -510K -466K -877K -60.13M -880K -6.05M -2.36M -30.42M -2.37M -2.32M -101M
Net Debt 2.92M 2.52M 2.36M 2.16M 4.06M 278M 4.07M 27.98M 10.93M 141M 10.95M 10.71M 467M 4.76M 4.11M 3.85M 3.52M 6.62M 454M 6.65M 45.67M 17.84M 230M 17.87M 17.49M 762M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-